Structure Therapeutics Inc. (GPCR) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$222.20M | -90.5% |
| 2024 | -$116.64M | -46.7% |
| 2023 | -$79.49M | -72.4% |
| 2022 | -$46.12M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$222.20M | -90.5% |
| 2024 | -$116.64M | -46.7% |
| 2023 | -$79.49M | -72.4% |
| 2022 | -$46.12M | — |